UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A825-A825

2023

Volltextzugriff (PDF)

Abstract CT128: IMU-201-101 - an open-label, multi-center, dose escalation/expansion, phase 1 study of IMU-201 (PD1-Vaxx), a B-cell immunotherapy, in adults with non-small cell lung cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT128-CT128

2020

Volltextzugriff (PDF)

HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16065-e16065

2021

Volltextzugriff (PDF)

A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4030-4030

2019

Volltextzugriff (PDF)

Abstract CT059: A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT059-CT059

2019

Volltextzugriff (PDF)

A phase Ib/II open label study of IMU-131 HER2/Neu peptide vaccine plus cisplatin and either 5-fluorouracil or capecitabine chemotherapy in patients with HER2/Neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS176-TPS176

2019

Volltextzugriff (PDF)

Abstract 6788: hNIS imaging data from a first-in-human trial of the oncolytic virus CF33-hNIS-antiPD-L1 in patients with triple negative breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6788-6788

2023

Volltextzugriff (PDF)

Abstract OT3-03-01: Phase I study of intratumoral administration of CF33-hNIS-antiPD-L1 (CHECKvacc) in patients with metastatic triple negative breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT3-03-01-OT3-03-01

2023

Volltextzugriff (PDF)

On the web this week: www.matchesfashion.com

Drapers, 2011-02, p.26-26

Ede, Nick

2011

Volltextzugriff (PDF)

On the web this week: www.yoox.com

Drapers, 2010-05, p.18-18

Ede, Nick

2010

Volltextzugriff (PDF)

Finding a way towards Population Health Management on the Central Coast, Australia

International journal of integrated care, 2023-12, Vol.23 (S1), p.117

2023

Volltextzugriff (PDF)

The start of a Population Health Management Maturity Index: an international Delphi round

International journal of integrated care, 2022-11, Vol.22 (S3), p.176

2022

Volltextzugriff (PDF)

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

The lancet respiratory medicine, 2017-10, Vol.5 (10), p.785-794

2017

Volltextzugriff (PDF)

Count Me In: an inclusive approach towards patient recruitment for clinical research studies in the NHS

BMJ mental health, 2023-10, Vol.26 (1), p.e300774

2023

Volltextzugriff (PDF)

Informing National Health Service patients about participation in clinical research: A comparison of opt-in and opt-out approaches across the United Kingdom

Australian and New Zealand journal of psychiatry, 2021-04, Vol.55 (4), p.400-408

2021

Volltextzugriff (PDF)

Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health Trusts

Evidence-based mental health, 2021-11, Vol.24 (4), p.161-166

2021

Volltextzugriff (PDF)

Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site

Chembiochem : a European journal of chemical biology, 2011-10, Vol.12 (15), p.2311-2315

2011

Volltextzugriff (PDF)

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

The lancet respiratory medicine, 2024-04, Vol.12 (4), p.e21-e30

2024

Volltextzugriff (PDF)

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

The Lancet (British edition), 2018-09, Vol.392 (10151), p.940-949

2018

Volltextzugriff (PDF)

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial

Journal of the American Heart Association, 2022-05, Vol.11 (10), p.e024291-e024291

2022

Volltextzugriff (PDF)

Counterstatement: Autobiography in Composition Scholarship

College English, 2005, Vol.68 (2), p.209-225

Williams, James D.

2005

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Humans
(6)
General & Internal Medicine
(3)
Psychiatry
(3)
Adult Psychiatry
(2)
Aged
(2)
Critical Care Medicine
(2)
Double-Blind Method
(2)
Female
(2)
Focus Groups
(2)
Health Services
(2)
Hypertension, Pulmonary - Drug Therapy
(2)
Male
(2)
Mental Health Care
(2)
Middle Aged
(2)
Patients
(2)
Respiratory System
(2)
State Medicine
(2)
Ticagrelor
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or advanced solid tumors

Abstract CT128: IMU-201-101 - an open-label, multi-center, dose escalation/expansion, phase 1 study of IMU-201 (PD1-Vaxx), a B-cell immunotherapy, in adults with non-small cell lung cancer

HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

A phase Ib study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Abstract CT059: A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity and clinical response in patients with HER2/Neu overexpressing advanced cancer of the stomach

A phase Ib/II open label study of IMU-131 HER2/Neu peptide vaccine plus cisplatin and either 5-fluorouracil or capecitabine chemotherapy in patients with HER2/Neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Abstract 6788: hNIS imaging data from a first-in-human trial of the oncolytic virus CF33-hNIS-antiPD-L1 in patients with triple negative breast cancer

Abstract OT3-03-01: Phase I study of intratumoral administration of CF33-hNIS-antiPD-L1 (CHECKvacc) in patients with metastatic triple negative breast cancer

On the web this week: www.matchesfashion.com

On the web this week: www.yoox.com

Finding a way towards Population Health Management on the Central Coast, Australia

The start of a Population Health Management Maturity Index: an international Delphi round

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Count Me In: an inclusive approach towards patient recruitment for clinical research studies in the NHS

Informing National Health Service patients about participation in clinical research: A comparison of opt-in and opt-out approaches across the United Kingdom

Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health Trusts

Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial

Counterstatement: Autobiography in Composition Scholarship

Suchergebnisse filtern